Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;8(3):263-270.
doi: 10.1177/2050640620901960. Epub 2020 Jan 14.

Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease

Affiliations
Review

Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease

Sara El Ouali et al. United European Gastroenterol J. 2020 Apr.

Abstract

Stricturing Crohn's disease (CD) is a significant clinical problem. The presence of a stricture may be suggested by clinical symptoms. Cross-sectional imaging using computed tomography or magnetic resonance enterography is essential in diagnosing strictures as it allows further characterization and evaluation for complications such as abscess, fistulizing disease or malignancy. Managing small bowel stricturing CD should be approached in a multidisciplinary fashion. Medical therapy can be considered in strictures which are not associated with complications, with most of the data supporting anti-TNF strategies in this setting. If the disease is refractory to medical therapy, endoscopic therapy or surgery should be performed. Endoscopic balloon dilation (EBD) is an option for short, uncomplicated and straight strictures that are within reach of a colonoscope. Although EBD has good short-term outcomes, repeat dilation is often required. Surgical options mainly include resection and strictureplasty. Strictures refractory to medical therapy, not amenable or refractory to EBD, or associated with complications or malignancy should be managed surgically. However, surgery may also be considered at an earlier stage depending on disease characteristics and patient preference. Postoperative recurrence is common, highlighting the importance of careful monitoring of the patient postoperatively and optimization of medical management accordingly. There is a pressing need to develop anti-fibrotics for the treatment of stricturing CD. This requires the development of standardized diagnostic criteria, patient-reported outcome measures and validation of endpoints in fibrostenotic CD. The STAR consortium is pioneering this effort in order to allow development and testing of anti-fibrotics in future clinical trials.

Keywords: Crohn’s disease; Stricture; endoscopic balloon dilation; fibrosis; inflammatory bowel disease; stenosis; surgery.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Key considerations prior to endoscopic balloon dilation of IBD strictures.
Figure 2.
Figure 2.
Short and long-term outcomes of EBD: Symptom recurrence, need for re-dilation and need for surgery at 6, 12 and 24 months. Adapted from Bettenworth et al.

References

    1. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn’s disease according to the Vienna classification: Changing pattern over the course of the disease. Gut 2001; 49: 777–782. - PMC - PubMed
    1. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology 2010; 139: 1147–1155. - PMC - PubMed
    1. Rieder F, Zimmermann EM, Remzi FH, et al. Crohn’s disease complicated by strictures: A systematic review. Gut 2013; 62: 1072–1084. - PMC - PubMed
    1. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990; 99: 956–963. - PubMed
    1. Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 2017; 152: 340–350.e6. - PMC - PubMed

MeSH terms